| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Qiagen has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for SERVICES TO MEDICAL PROF | 18 |
$49 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Instrumentation Intelligence Monitor: overall outlook STRONG - 20 new Leaders; 12 new Laggards. | 47 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) | 34 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 | 447 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for QGEN | 13 |
$25 |
| 23-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 21-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: QIAGEN NV | 5 |
$25 |
0.29% Nasdaq 
Research Reports
